Despite all of today’s options for optimizing the bioprocessing of fungal secondary metabolites, researchers pointed out the ...

The field of plant biotechnology is undergoing a profound transformation. The rise of generative artificial intelligence (AI) ...

Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications; Inno ...

Illuminating key biological pathways that underlie neurodevelopmental and psychiatric disorders, such as autism spectrum disorder and attention deficit hyperactivity disorder, is the goal of a new ...

ioTracker Cells, the new range within bit.bio's ioCells portfolio, deliver added visualisation capabilities that enhance the portfolio of deterministically-programmed human iPSC-derived cells powered ...

“By enhancing our CRISPR expertise with AstraZeneca’s novel nuclease, we are poised to expedite the development of transformative therapies, paving a streamlined and accelerated path to clinical ...

By 2025, innovations such as lab-on-a-chip technology, automation, and CRISPR-Cas9 gene editing are expected to ... of gonadotropins and portable ultrasound devices are expected to simplify monitoring ...

Artificial intelligence (AI) is redefining how machines process and deliver information. Two of the most exciting approaches in this domain—Retrieval-Augmented Generation (RAG) and ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...